Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

BACKGROUND: The clinical benefit of allergen-specific immunotherapy (AIT) involves induction of blocking antibodies. It is not clear if these antibodies function via steric hindrance alone or a combination of levels, avidities, and epitope specificities, and clinical outcome cannot be predicted. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Sara, Lang, Roland, Steiner, Markus, Aglas, Lorenz, Ferreira, Fatima, Wallner, Michael, Hawranek, Thomas, Gadermaier, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174570/
https://www.ncbi.nlm.nih.gov/pubmed/30338052
http://dx.doi.org/10.1186/s13601-018-0226-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174570/
https://www.ncbi.nlm.nih.gov/pubmed/30338052
http://dx.doi.org/10.1186/s13601-018-0226-7

Ejemplares similares